Pascal Borderies

Biography

 Pascal Borderies joined Vernalis in September 2014. A physician by training who initially focused on clinical pharmacology, Pascal provides leadership and has oversight for all clinical development, medical affairs, regulatory and pharmacovigilance activities of the commercial and development portfolio of the company. Prior to joining Vernalis, Pascal held positions of increasing responsibility on both the R&D and the business sides in various pharma/biotech companies, managing prescriptions and OTC products in Primary Care and other Specialty markets. Most recently, Pascal was the Senior Director Clinical Strategy & Development in the Pharmaceutical Technologies division of Aptalis Pharma, Inc. Before, he was Director – Global Head Cough-Cold Respiratory, Pain and New Growth Opportunities and Director Search and Evaluate in the OTC Business Unit of Novartis Consumer Health, Inc., Senior Director Commercial Development Allergy, Respiratory, Primary Care and Women's Health at Schering-Plough Corp., Executive Director Commercial Development & Marketing/BD at Genaissance Pharmaceuticals Inc., and Director Marketing at Sanofi-Synthélabo Inc. Pascal earned his Medical Degree from the School of Medicine of the University Paris 12 Val de Marne in France.

Research Interest

 Dr. Pascal Borderies having research interest in Global Marketing, pharmaceutical management, biotech industry, global business, Licensing, Manufacturing, Marketing and Sales and Research & Clinical Development.